170349 ⎘
Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from protozoa Toxoplasma
Methods and Reagents for Toxoplasma Infection Diagnosis
#2ANTIGENIC REGIONS FOR THE DETECTION OF ANTI-TOXOPLASMA GONDII IGM ANTIBODIES
#3TREATMENT AND DIAGNOSIS OF TOXOPLASMA-ASSOCIATED DISEASE
#4VIRUS-LIKE PARTICLE COMPRISING TOXOPLASMA GONDII PROTEIN AND INFLUENZA VIRUS PROTEIN, AND DIAGNOSTIC METHOD USING SAME
#5FERROFLUID-BASED ASSAY METHODS, AND SYSTEMS FOR PARASITE EGGS OR OOCYSTS DETECTION
#6ASSAYS FOR DETERMINIG THE PATHOGENCITY OF TOXOPLASMA INFECTIONS
#7NEW SEROLOGICAL MARKER FOR THE LATENT FORM OF TOXOPLASMOSIS
#8ASSAYS FOR DETERMINIG THE PATHOGENCITY OF TOXOPLASMA INFECTIONS
#9ASSAYS FOR DETERMINIG THE PATHOGENCITY OF TOXOPLASMA INFECTIONS
#10Antibodies to the surface of oocysts and methods of use thereof
#11In vivo induced toxoplasma gondii protein for application in diagnosis, vaccine and therapy
#12Recombinant GRA antigens and the use of same for early diagnosis of toxoplasmosis
#13Protein microarray for characterizing the specificity of the monoclonal immunoglobulins of MGUS or myeloma patients
#14Synthesis of diverse glycosylphosphatidylinositol glycans from and their application as vaccines and diagnostics
#15Method of neonatal serological diagnosis
#16Mutant parasites for use as vaccines and platforms for screening for compounds
#17oocyst protein
#18Toxoplasma gondii Oocyst Protein
#19Detection of primary infections with pathogens
#20Genetically engineered P30 antigen, improved antigen cocktail, and uses thereof
#21Methods for the determination of antibody IgG avidity
#22Toxoplasma gondii cylclic GMP dependent protein kinase G as a chemotherapeutic target for antiprotozoal agents
#23Polynucleotide encoding a genetically engineered P30 antigen
#24Method for detection of malaria and other parasite infections
#25Serological assay for Neospora caninum